Line 9: | Line 9: | ||
background: url(https://static.igem.org/mediawiki/2017/6/68/Aqaunesp-main-header.png) no-repeat center center; | background: url(https://static.igem.org/mediawiki/2017/6/68/Aqaunesp-main-header.png) no-repeat center center; | ||
width: 100%; | width: 100%; | ||
− | height: | + | height: 100%; |
overflow:hidden; | overflow:hidden; | ||
background-size: cover; | background-size: cover; | ||
+ | min-height: 100%; | ||
+ | display: -webkit-flex; | ||
+ | display: flex; | ||
+ | -webkit-align-items: center; | ||
+ | align-items: center; | ||
+ | -webkit-justify-content: center; | ||
+ | justify-content: center; | ||
} | } | ||
Revision as of 13:37, 1 November 2017
iGEM AQA_Unesp
INSUBIOTA
treating diabetes with genetically engineered probiotic